A wearable patch for continuous analysis of thermoregulatory sweat at rest

HYY Nyein, M Bariya, B Tran, CH Ahn, BJ Brown… - Nature …, 2021 - nature.com
The body naturally and continuously secretes sweat for thermoregulation during sedentary
and routine activities at rates that can reflect underlying health conditions, including nerve …

The prevalence of anxiety disorders in dermatology outpatients: A systematic review and meta‐analysis

B Storer, KA Kershaw, TA Braund… - Journal of the …, 2023 - Wiley Online Library
Anxiety is common in those with medical conditions and has significant impacts on mental
well‐being as well as physical health outcomes. While several systematic reviews have …

Treatment of hyperhidrosis: an update

MAS Henning, D Bouazzi, GBE Jemec - American Journal of Clinical …, 2022 - Springer
Hyperhidrosis is a dermatosis presenting as pathologically excessive focal or generalized
sweating. The stigmatizing nature of hyperhidrosis may cause patients to feel …

Hyperhidrosis: an update on prevalence and severity in the United States

J Doolittle, P Walker, T Mills, J Thurston - Archives of dermatological …, 2016 - Springer
Current published estimates of the prevalence of hyperhidrosis in the United States are
outdated and underestimate the true prevalence of the condition. The objectives of this study …

[HTML][HTML] Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled …

DA Glaser, AA Hebert, A Nast, WP Werschler… - Journal of the American …, 2019 - Elsevier
Background Glycopyrronium tosylate (GT) is a topical anticholinergic developed for once-
daily treatment of primary axillary hyperhidrosis. Objective Assess the efficacy and safety of …

A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial

C Abels, M Soeberdt, A Kilic, H Reich… - British Journal of …, 2021 - academic.oup.com
Background Effective topical treatment options for patients with primary axillary
hyperhidrosis (PAHH) are limited. A phase I trial showed promising results regarding the …

[HTML][HTML] Association of primary hyperhidrosis with depression and anxiety: a systematic review

JK Kristensen, DG Vestergaard… - Acta Dermato …, 2020 - ncbi.nlm.nih.gov
METHODS The medical databases PubMed, Embase and PsycINFO were searched using
the following terms: primary hyperhidrosis AND depression OR suicide OR suicidal ideation …

Treatment patterns, depression, and anxiety among US patients diagnosed with hyperhidrosis: a retrospective cohort study

SZ Klein, M Hull, KK Gillard… - Dermatology and Therapy, 2020 - Springer
Introduction Hyperhidrosis is associated with social and emotional stress due to limitations
on health-related quality of life. This study examined real-world treatment patterns and …

Long‐term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial

RM Szeimies, C Abels, A Kilic, H Reich… - Journal of the …, 2023 - Wiley Online Library
Background Primary axillary hyperhidrosis (PAHH) strongly affects the patient's quality of
life. To date, topical treatment options are limited. One percent glycopyrronium bromide …

Chinese expert consensus on the surgical treatment of primary palmar hyperhidrosis (2021 version)

Y Liu, W Weng, Y Tu, J Wang - Chinese Medical Journal, 2022 - mednexus.org
Primary palmar hyperhidrosis (PPH) is a pathologic condition of excessive sweating on
hands that has adverse impacts on patients' social activity, professional life, and …